Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Xinyu Modern Biological Technology is a leading Chinese biotechnology firm specializing in the research, development, and production of biological products derived from aquatic resources, specifically sturgeon. The company is a dominant global supplier of Protamine Sulfate, an essential active pharmaceutical ingredient (API) used to neutralize heparin's anticoagulant effects during cardiac and vascular surgeries. In addition to its pharmaceutical APIs, Xinyu produces high-purity DNA extracts and other bioactive compounds for the medical, cosmetic, and nutritional sectors. The firm maintains integrated capabilities from raw material sourcing to advanced purification, ensuring high standards for its biological extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan New Fishing Modern Biological Technology.